Lutetium-177 Labeled Therapeutics: ¹⁷⁷Lu-PSMA is Set to Redefine Prostate Cancer Treatment. 2016

Ambikalmajan M R Pillai, and Furn F Russ Knapp

UI MeSH Term Description Entries
D008187 Lutetium An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175.
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D043425 Glutamate Carboxypeptidase II A metallocarboxypeptidase that is predominantly expressed as a membrane-bound enzyme. It catalyzes the hydrolysis of an unsubstituted, C-terminal glutamyl residue, typically from PTEROYLPOLYGLUTAMIC ACIDS. It was formerly classified as EC 3.4.19.8. FOLH1 Protein,Folate Hydrolase I,N-Acetylaspartylglutamate Peptidase,N-Acetylated-alpha-Linked Acidic Dipeptidase,NAAG Peptidase,NAALADase,NAALADase II,NAALADase L,Acidic Dipeptidase, N-Acetylated-alpha-Linked,Carboxypeptidase II, Glutamate,Dipeptidase, N-Acetylated-alpha-Linked Acidic,Hydrolase I, Folate,N Acetylaspartylglutamate Peptidase,N Acetylated alpha Linked Acidic Dipeptidase,Peptidase, N-Acetylaspartylglutamate
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Ambikalmajan M R Pillai, and Furn F Russ Knapp
December 2021, The New England journal of medicine,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
December 2021, The New England journal of medicine,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
December 2021, The New England journal of medicine,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
December 2021, The New England journal of medicine,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
December 2022, The Medical letter on drugs and therapeutics,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
July 2016, Journal of labelled compounds & radiopharmaceuticals,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
March 2023, Nederlands tijdschrift voor geneeskunde,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
March 2023, Nederlands tijdschrift voor geneeskunde,
Ambikalmajan M R Pillai, and Furn F Russ Knapp
April 2018, Clinical genitourinary cancer,
Copied contents to your clipboard!